GeneDx Holdings Corp. (WGS)
GeneDx Holdings Corp. operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Stamford, CT, US. The stock last traded at $82.00, up 0.32% on the session, giving a market capitalisation of $2.45B. On trailing twelve-month figures it carries a trailing P/E of -22.53, a net margin of -23.4%. Its beta of 1.98 implies it has historically moved more than the broad market.
GeneDx Holdings Corp. functions as a health intelligence firm singularly focused on the individual patient. It aims to revolutionize healthcare delivery by deploying advanced artificial intelligence and machine learning capabilities. These sophisticated algorithms are applied to vast, longitudinal clinical and genomic datasets to construct comprehensive, dynamic models of human health, ultimately defining personalized, optimal pathways for each person's well-being. Through its exclusive Centrellis health intelligence platform, the company gains profound insights into both disease states and overall wellness, enabling it to furnish evidence-based solutions for the most critical medical challenges. Eric Schadt established the corporation in October 2015, and its principal offices are located in Stamford, Connecticut.
GeneDx Holdings Corp. is most often compared with the following Healthcare names: